We represent clients in the pharmaceutical and biotechnology industries, as well as contract manufacturing organizations (CMOs) and private equity and venture capital firms focused on the life sciences market.
Our practice focuses on complex business transactions and assisting companies in the acquisition, divestiture and commercialization of their intellectual property assets.
We help our pharma and biotech clients grow their businesses through strategic transactions, including the structure, negotiate and document domestic and international corporate transactions including product-line and company acquisitions, NDA and ANDA sales and acquisitions, divestments, in-licenses and out-licenses, strategic alliances, and joint ventures, research and development agreements, marketing and distribution arrangements, manufacturing and supply agreements, clinical trial agreements and other strategic transactions.
We counsel companies with respect to the numerous compliance issues particular to the life sciences industry.
We assist clients with pharmaceutical state licensing, accreditation (NABP/VAWD) and DSCSA matters.